PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1334602
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1334602
Positron Emission Tomography (PET) is a mix of nuclear medicine and biochemical analysis that is used to measure the metabolic activity of cells. Through an intravenous (IV) line, an insignificant quantity of radioactive glucose (sugar) is injected into the patient's vein. A scanner and computer are used to create detailed images of places containing glucose. PET is used for the early identification of heart diseases, brain disorders, and cancer. The key factor driving the market growth is the growing target patient population, rising adoption of multimodal PET imaging devices, technological advancements in radiopharmaceuticals and PET systems, and rising investments, funds, and grants by public-private organizations that are anticipated to create the lucrative demand for the market.
Moreover, the rising prevalence of cardiovascular diseases has significantly contributed to the growth of the Positron Emission Tomography (PET) market. PET imaging plays a crucial role in the diagnosis and management of cardiovascular diseases. It provides detailed functional and anatomical information about the heart and blood vessels, allowing for the early detection and assessment of cardiovascular conditions. Thus, the rising prevalence of cardiovascular diseases is anticipated to support market growth. according to the research study published in December 2021, by Elsevier, for older people aged 45 and above, the overall self-reported prevalence of CVDs was 29.4%. The prevalence rate increased with age, from 22% in the 45-54 age group to 38% in the 70+ age group, showing that the old age population is at high risk of having CVDs. Additionally, the rising use of PET in breast cancer detection and improving healthcare infrastructure across emerging economies is anticipated to create a lucrative opportunity for the market during the forecast period. However, the availability of alternate imaging technologies stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Positron Emission Tomography Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing geriatric population, focus on reducing healthcare costs and government investments, and increasing prevalence of cancer in the region. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising adoption of advanced technologies, improving healthcare infrastructure, presence of advanced healthcare system, and rising investments in research and development.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable